apomorphine hcl sterop 5 mg/ml sol. inj./perf. s.c. amp.
laboratoires sterop sa-nv - chlorhydrate d'apomorphine 5 mg/ml - solution injectable/pour perfusion - 5 mg/ml - chlorhydrate d'apomorphine 5 mg/ml - apomorphine
apomorphine archimedes pharma france, solution injectable/pour perfusion
archimedes pharma france sarl - chlorhydrate d'apomorphine - solution - 10 mg - composition pour 1 ml > chlorhydrate d'apomorphine : 10 mg - agonistes dopaminergiques
apomorphine ever pharma 5 mg/ml, solution pour perfusion
ever neuro pharma gmbh - chlorhydrate d'apomorphine hémihydraté - solution - 5 mg - composition pour 1 ml de solution > chlorhydrate d'apomorphine hémihydraté : 5 mg - antiparkinsoniens dopaminergiques
apomorphine kalceks 5 mg/ml, solution pour perfusion
as kalceks - chlorhydrate d'apomorphine hémihydraté - solution - 5 mg - composition pour 1 ml de solution > chlorhydrate d'apomorphine hémihydraté : 5 mg - antiparkinsonien dopaminergique, agents dopaminergiques, agonistes dopaminergiques
sitagliptin / metformin hydrochloride sun
sun pharmaceutical industries europe b.v. - sitagliptin fumarate, metformin hydrochloride - diabète sucré, type 2 - les médicaments utilisés dans le diabète - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride sun is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride sun is indicated in combination with a sulphonylurea (i. triple thérapie de combinaison) en complément d'un régime alimentaire et l'exercice chez les patients insuffisamment contrôlés sur leur dose maximale tolérée de metformine et une sulphonylurea. sitagliptin/metformin hydrochloride sun is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. sitagliptin/metformin hydrochloride sun is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.
apo-go-amp 10 mg/ml sol. inj./perf. s.c. amp.
eg sa-nv - chlorhydrate d'apomorphine 10 mg/ml - solution injectable/pour perfusion - 10 mg/ml - chlorhydrate d'apomorphine 10 mg/ml - apomorphine
apo-go-amp 10 mg/ml sol. inj./perf. s.c. amp.
eg sa-nv - chlorhydrate d'apomorphine 10 mg/ml - solution injectable/pour perfusion - 10 mg/ml - chlorhydrate d'apomorphine 10 mg/ml - apomorphine
apo-go-pen 10 mg/ml sol. inj. s.c. cart.
eg sa-nv - chlorhydrate d'apomorphine 30 mg/3 ml - solution injectable - 10 mg/ml - chlorhydrate d'apomorphine 10 mg/ml - apomorphine
dacepton 5 mg/ml sol. perf. s.c. flac.
ever neuro pharma gmbh - chlorhydrate d'apomorphine 5 mg/ml - solution pour perfusion - 5 mg/ml - chlorhydrate d'apomorphine 5 mg/ml - apomorphine
dacepton 10 mg/ml sol. inj. s.c. cart.
ever neuro pharma gmbh - chlorhydrate d'apomorphine 10 mg - solution injectable en cartouche - 10 mg/ml - chlorhydrate d'apomorphine 10 mg/ml - apomorphine